A biomimetic mesenchymal stem cell membrane-coated nanodelivery system attenuates cardiac fibrosis by restoring mitochondrial homeostasis.
A mesenchymal stem cell membrane-coated biomimetic nanodelivery system with high drug loading capacity and pH-responsive release properties effectively attenuates myocardial fibrosis by restoring mitochondrial homeostasis, offering a promising targeted nanotherapeutic strategy for heart failure.